This is the first study to show significantly higher levels of VPACR2 receptors, CD4+CD25+Tregs and FoxP3+Treg expression in CFS/ME patients compared to healthy controls. This evidence concerns the gene FOXP3 and myalgic encephalomeyelitis/chronic fatigue syndrome.